The receptor tyrosine kinase MET is overexpressed in human colorectal adenomas and carcinomas, suggesting an instrumental role for MET signaling in the onset and progression of colorectal cancer. To corroborate this role, animal models are needed. To study the expression of Met in the normal and neoplastic mouse intestine, we generated an Armenian hamster monoclonal antibody against mouse Met. By using this antibody in immunohistochemical studies, we observed strong Met expression in fetal mouse intestinal epithelial cells. In contrast, in the intestines of adult mice, Met expression was very low whereas the protein was undetectable on the neoplastic epithelium of intestinal adenomas in Apc^+/min mice. By immunoblotting, we were also unable to detect Met in intestinal adenomas, whereas Met mRNA levels in microdissected adenomas were very low. The absence of detectable Met protein expression in adenomas of Apc^+/min mice contrasts sharply with the vast overexpression of the protein in adenomas of humans with familial adenomatous polyposis or sporadic colorectal carcinomas. Our results imply that deregulation of Wnt signaling in mouse − unlike in human − intestinal epithelium does not result in Met overexpression. Our findings thus reveal important interspecies differences in the regulation of Met expression during intestinal tumorigenesis. (Cancer Sci 2006; 97: 710–715)

References

1 Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404–10.
10.1016/S0962-8924(98)01359-2
CAS PubMed Web of Science® Google Scholar
2 Van Der Voort R, Taher TE, Derksen PW, Spaargaren M, Van Der Neut R, Pals ST. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 2000; 79: 39–90.
10.1016/S0065-230X(00)79002-6
CAS PubMed Web of Science® Google Scholar
3 Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995; 376: 768–71.
10.1038/376768a0
CAS PubMed Web of Science® Google Scholar
4 Schmidt C, Bladt F, Goedecke S et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699–702.
10.1038/373699a0
CAS PubMed Web of Science® Google Scholar
5 Uehara Y, Minowa O, Mori C et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702–5.
10.1038/373702a0
CAS PubMed Web of Science® Google Scholar
6 Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nature Rev Mol Cell Biol 2003; 4: 915–25.
10.1038/nrm1261
CAS PubMed Web of Science® Google Scholar
7 Wielenga VJ, Van Der Voort R, Taher TE et al. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am J Pathol 2000; 157: 1563–73.
10.1016/S0002-9440(10)64793-1
CAS PubMed Web of Science® Google Scholar
8 Boon EM, Van Der Neut R, Van de Wetering M, Clevers H, Pals ST. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 2002; 62: 5126–8.
CAS PubMed Web of Science® Google Scholar
9 Di Renzo MF, Olivero M, Giacomini A et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147–54.
CAS PubMed Web of Science® Google Scholar
10 Boivin GP, Washington K, Yang K et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterol 2003; 124: 762–77.
10.1053/gast.2003.50094
PubMed Web of Science® Google Scholar
11 Fodde R, Smits R. Disease model: familial adenomatous polyposis. Trends Mol Med 2001; 7: 369–73.
10.1016/S1471-4914(01)02050-0
CAS PubMed Web of Science® Google Scholar
12 Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223–35.
10.1083/jcb.123.1.223
CAS PubMed Web of Science® Google Scholar
13 Yang XM, Park M. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse. Lab Invest 1995; 73: 483–91.
CAS PubMed Web of Science® Google Scholar
14 Hamann J, Van Zeventer C, Bijl A, Molenaar C, Tesselaar K, Van Lier RA. Molecular cloning and characterization of mouse CD97. Int Immunol 2000; 12: 439–48.
10.1093/intimm/12.4.439
CAS PubMed Web of Science® Google Scholar
15 Sheng H, Shao J, Williams CS et al. Nuclear translocation of β-catenin in hereditary and carcinogen induced intestinal adenomas. Carcinogenesis 1998; 19: 543–9.
10.1093/carcin/19.4.543
CAS PubMed Web of Science® Google Scholar
16 Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol Cell Biol 2001; 21: 5857–68.
10.1128/MCB.21.17.5857-5868.2001
CAS PubMed Web of Science® Google Scholar
17 Taher TE, Tjin EP, Beuling EA, Borst J, Spaargaren M, Pals ST. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J Immunol 2002; 169: 3793–800.
10.4049/jimmunol.169.7.3793
CAS PubMed Web of Science® Google Scholar
18 Wright TG, Tsai J, Jia Z, Elliott BE. Inhibition by copper (II) binding of hepatocyte growth factor (HGF) interaction with its receptor Met and blockade of HGF/Met function. J Biol Chem 2004; 279: 32 499–506.
10.1074/jbc.M405043200
CAS Web of Science® Google Scholar
19 Wielenga VJ, Smits R, Korinek V et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515–23.
10.1016/S0002-9440(10)65297-2
CAS PubMed Web of Science® Google Scholar
20 Boon EMJ, Kovarikova M, Derksen PWB, Van Der Neut R. Met signalling in primary colon epithelial cells leads to increased transformation irrespective of aberrant WNT signaling. Br J Cancer 2005; 92: 1078–83.
10.1038/sj.bjc.6602405
CAS PubMed Web of Science® Google Scholar
21 He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509–12.
10.1126/science.281.5382.1509
CAS PubMed Web of Science® Google Scholar
22 Huff JL, Jelinek MA, Borgman CA, Lansing TJ, Parsons JT. The protooncogene c-sea encodes a transmembrane protein–tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci USA 1993; 90: 6140–4.
10.1073/pnas.90.13.6140
CAS PubMed Web of Science® Google Scholar
23 Ronsin C, Muscatelli F, Mattei MG, Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene 1993; 8: 1195–202.
CAS PubMed Web of Science® Google Scholar
24 Chen YQ, Zhou YQ, Angeloni D, Kurtz AL, Qiang XZ, Wang MH. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines. Exp Cell Res 2000; 261: 229–38.
10.1006/excr.2000.5012
CAS PubMed Web of Science® Google Scholar
25 Zhou YQ, He C, Chen YQ, Wang D, Wang MH. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 2003; 22: 186–97.
10.1038/sj.onc.1206075
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume97, Issue8

August 2006

Pages 710-715

Activation of Wnt signaling in the intestinal mucosa of Apc^+/min mice does not cause overexpression of the receptor tyrosine kinase Met

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Activation of Wnt signaling in the intestinal mucosa of Apc+/min mice does not cause overexpression of the receptor tyrosine kinase Met

Abstract

References

Citing Literature

References

Related

Information

Activation of Wnt signaling in the intestinal mucosa of Apc^+/min mice does not cause overexpression of the receptor tyrosine kinase Met